Related Experiment Videos
Ectomesenchymoma of the prostate: histological diagnostic criteria
1Department of Pathology, University of Natal Medical School, Private Bag 7, Congella, 4013, Durban, South Africa and King Edward VIII Hospital, Durban, South Africa.
Insights
Ectomesenchymoma (EMCH) in infants is rare, presenting diagnostic challenges. Early and accurate diagnosis of this prostate tumor, a mix of embryonal rhabdomyosarcoma and ganglioneuroma, is crucial.
Area of Science:
- Pediatric Oncology
- Surgical Pathology
- Developmental Biology
Background:
- Ectomesenchymoma (EMCH) is a rare tumor comprising neuroectodermal and mesenchymal elements.
- Prostate tumors in infants are uncommon, posing diagnostic difficulties.
- Embryonal rhabdomyosarcoma (RMS) is a common pediatric malignancy, but EMCH is a distinct entity.
Observation:
- A case of a 5-month-old infant with a prostate ectomesenchymoma (EMCH) is presented.
- The tumor demonstrated features of both embryonal rhabdomyosarcoma (RMS) and ganglioneuroma.
- The infant experienced tumor recurrence and intestinal obstruction, leading to death eight months post-diagnosis.
Findings:
- Initial trans-rectal needle biopsies misdiagnosed the tumor as solely embryonal RMS.
- Diagnosing EMCH from needle biopsies is challenging due to its mixed histology.
- Immunohistochemical stains are recommended for differentiating RMS from neuroectodermal components.
Implications:
- Pathologists should consider EMCH in the differential diagnosis of pediatric prostate tumors with RMS or neuroectodermal features.
- Accurate diagnosis of EMCH is critical for appropriate treatment and prognosis.
- Further research into the pathogenesis and optimal management of pediatric EMCH is warranted.
Abstract:
A 5-month-old infant with an ectomesenchymoma (EMCH) of the prostate is described. The tumour was composed of embryonal rhabdomyosarcoma (RMS) and ganglioneuroma. Eight months after presentation the patient died of recurrent tumour, which caused intestinal obstruction. The tumour was initially diagnosed as an embryonal RMS on trans-rectal needle biopsies. The diagnosis of an EMCH is difficult if not impossible to make on needle-biopsy specimens. We suggest that pathologists should always consider an EMCH when confronted with a RMS or neuroectodermal tumour, and the use of immunohistochemical stains is recommended in this situation.